Genetic testing study for early stomach cancer and stomach polyps
Part of Cancer, Digestive system clinical trials.
This study uses genetic sequencing to learn more about early stomach cancer and precancerous stomach polyps. It may help improve how these conditions are understood and potentially guide future care, using genetic information from stored tissue samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- Your diagnosis is confirmed as early stomach cancer or a precancerous stomach adenoma (a type of stomach polyp)
- You have extra stored tissue from a prior biopsy or endoscopy done for diagnosis or treatment
- Your doctors expect you will likely live more than 3 months
- You are willing to sign informed consent (agree to join the study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses high-definition endoscopy to look at early changes in the stomach lining that might lead to cancer. It aims to better understand these changes in people having a routine upper endoscopy for stomach-related symptoms.
This study looks at people with early-stage stomach cancer to learn more about how different treatments work. It uses information from patients who were treated at a specific hospital, which may help doctors better understand the best ways to treat this condition.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This study follows people over 40 who may be at higher risk for stomach cancer. It uses regular check-ups to catch cancer early, without testing any new treatments.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.